Management of dyslipidemia in pediatric renal transplant recipients.

Clicks: 318
ID: 75922
2020
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Dyslipidemia after kidney transplantation is a common complication that has historically been underappreciated, especially in pediatric recipients. It is also a major modifiable risk factor for cardiovascular disease, a top cause of morbidity and mortality of transplant patients. While most knowledge about post-transplant dyslipidemia has been generated in adults, recommendations and treatment strategies also exist for children and are presented in this review. Awareness of these applicable guidelines and approaches is required, but not sufficient, for the reliable management of dyslipidemia in our patients, and additional needs and opportunities for comprehensive care in this area (e.g., quality improvement) are outlined.
Reference Key
bock2020managementpediatric Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bock, Margret E;Wall, Leslie;Dobrec, Carly;Chandran, Mary;Goebel, Jens;
Journal pediatric nephrology (berlin, germany)
Year 2020
DOI
10.1007/s00467-019-04428-y
URL
Keywords
pediatric kidney triglycerides dyslipidemia cholesterol transplant

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.